Registry of Myriad™ Utilization in Soft Tissue Reconstruction Procedures
Status: Recruiting
Location: See all (15) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll participants who are undergoing a surgical procedure, where the attending physician will use Myriad™ as part of the surgical intervention.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Willing and able to provide written informed consent and to comply with the requirements of Clinical Investigational Plan
• Male or female patients aged 18 years or above
• Patients where Matrix and/or Morcells were used as part of their soft tissue reconstruction procedure
• Subject that are willing and able to comply with all aspects of the treatment and evaluation schedule
Locations
United States
Arizona
The Diane & Bruce Halle Arizona Burn Center at Valleywise Health
ENROLLING_BY_INVITATION
Phoenix
California
Surgery Group LA
COMPLETED
Los Angeles
Florida
Associates in Medicine & Surgery
ACTIVE_NOT_RECRUITING
Fort Myers
Asencion Sacred Heart
RECRUITING
Pensacola
Georgia
Northeast Georgia Medical Center, Inc.
RECRUITING
Gainesville
Iowa
University of IOWA Health Care
ENROLLING_BY_INVITATION
Iowa City
Louisiana
Ochsner Baptist Medical Center
ENROLLING_BY_INVITATION
New Orleans
University Medical Center
RECRUITING
New Orleans
Maryland
Sinai Hospital of Baltimore
RECRUITING
Baltimore
North Carolina
Moses H Cone Memorial Hospital Operating Corporation
COMPLETED
Greensboro
New York
Nuvance Health Vassar Brothers Medical Center
ENROLLING_BY_INVITATION
Poughkeepsie
Ohio
Ohio State University Wexner Medical Center
ENROLLING_BY_INVITATION
Columbus
Pennsylvania
Lancaster General Hospital
RECRUITING
Lancaster
Tower Health Reading Hospital
ENROLLING_BY_INVITATION
West Reading
Wisconsin
The Medical College of Wisconsin
RECRUITING
Milwaukee
Contact Information
Primary
Barnaby May, PhD
barnaby.may@aroa.com
+64 21 056 9995
Backup
Brandon Bosque, DMP,CWSP
Brandon.Bosque@aroa.com
Time Frame
Start Date: 2022-01-10
Estimated Completion Date: 2029-01
Participants
Target number of participants: 800
Treatments
Myriad™
Ovine forestomach matrix sheet graft and morselized extracellular matrix
Authors
Related Therapeutic Areas
Sponsors
Leads: Aroa Biosurgery Limited